Evidence map›Paper›PMID 39007445›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2024

Pilot Study of Acute Behavioral Effects of Pallidal Burst Stimulation in Parkinson's Disease.

Saar Kariv, Jeong Woo Choi, Koorosh Mirpour, Ann M Gordon, Amirreza Alijanpourotaghsara, Mohsen Benam, Ruwayd Abdalla, Sahil Chilukuri, Jianwen W Gu, Hemant Bokil and 3 more

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Saar KarivDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0009-0005-6121-2749
Jeong Woo ChoiDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0001-5824-8859
Koorosh MirpourDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-8187-9015
Ann M GordonDepartment of Neurology, UT Southwestern Medical Center, Dallas, Texas, USA.
Amirreza AlijanpourotaghsaraDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0001-6942-9997
Mohsen BenamDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Ruwayd AbdallaDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Sahil ChilukuriDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Jianwen W GuBoston Scientific Neuromodulation, Valencia, California, USA.
Hemant BokilBoston Scientific Neuromodulation, Valencia, California, USA.
Shruti NanivadekarNeuroscience Institute, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-0091-9442
Aryn H GittisNeuroscience Institute, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-3591-5775
Nader PouratianDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-0426-3241

Funding

The Pathophysiology of Network Synchrony in Parkinson's DiseaseR01NS097782 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI NADER POURATIAN · 2016 to 2026
$5.2M
Circuit-Inspired Strategies to Restore Basal Ganglia Function in Mouse Models of Parkinson’s DiseaseR35NS132213 · NINDS · CARNEGIE-MELLON UNIVERSITY · PI Aryn Hilary Gittis · 2023 to 2026
$2.8M
DELINEATING CELL-SPECIFIC OUTPUT PATHWAYS OF THE GPe THAT SUPPORT LONG-LASTING BEHAVIORAL RECOVERY IN DOPAMINE DEPLETED MICER01NS104835 · NINDS · CARNEGIE-MELLON UNIVERSITY · PI GITTIS, ARYN HILARY · 2018 to 2022
$1.9M
Cell-type Specific Neuromodulation Using Burst DBS Produces Long-lasting Behavioral and Physiological Rescue in a Parkinsonian Mouse ModelF31NS127483 · NINDS · CARNEGIE-MELLON UNIVERSITY · PI NANIVADEKAR, SHRUTI · 2022 to 2024
$133k
NINDS NIH HHS F31NS127483NINDS NIH HHS R01 NS097782NINDS NIH HHS R01NS104835NINDS NIH HHS R35 NS132213NINDS NIH HHS R35NS132213The Michael J. Fox Foundation
6 · The paper itself

Abstract

backgroundBurst-patterned pallidal deep brain stimulation (DBS) in an animal model of Parkinson's disease (PD) yields significantly prolonged therapeutic benefit compared to conventional continuous DBS, but its value in patients remains unclear.

objectivesThe aims were to evaluate the safety and tolerability of acute (<2 hours) burst DBS in PD patients and to evaluate preliminary clinical effectiveness relative to conventional DBS.

methodsSix PD patients were studied with DBS OFF, conventional DBS, and burst DBS. Unified Parkinson's Disease Rating Scale III (UPDRS-III) and proactive inhibition (using stop-signal task) were evaluated for each condition.

resultsBurst and conventional DBS were equally tolerated without significant adverse events. Both stimulation patterns provided equivalent significant UPDRS-III reduction and increased proactive inhibition relative to DBS OFF.

conclusionsThis pilot study supports the safety and tolerability of burst DBS, with acute effects similar to conventional DBS. Further larger-scale studies are warranted given the potential benefits of burst DBS due to decreased total energy delivery. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Deep Brain StimulationGlobus PallidusParkinson DiseaseAgedFemaleHumansMaleMiddle AgedPilot ProjectsSeverity of Illness IndexTreatment Outcomeburst stimulationdeep brain stimulationParkinson's disease

Identifiers

PMID39007445
PMCPMC11883832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.